To investigate the suitability of S100A9‐targeted VNPs to serve as a prophylactic immunotherapy preventing manifestation of lung metastasis, we used a lung metastasis mouse model using C57BL/6J mice i.v. challenged with B16F10 melanoma cells. The gene discussed is S100A9; the disease is melanoma.